Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.
about
Use of bortezomib as induction therapy prior to stem cell transplantation in frontline treatment of multiple myeloma: impact on stem cell harvesting and engraftment.Intensive treatment for multiple myeloma: where do we stand?Impact of informative censoring on the Kaplan-Meier estimate of progression-free survival in phase II clinical trialsInterferon and cytotoxic chemotherapy for the treatment of post-transplant lymphoproliferative disorder.Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a review.Multiple myeloma: an update of developments in targeted therapy.Current treatment options for myeloma.High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma.Pharmacotherapy of multiple myeloma.High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging.Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches.Association of response endpoints with survival outcomes in multiple myeloma.Human herpesvirus 8 (KSHV) contamination of peripheral blood and autograft products from multiple myeloma patients.The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma.Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes.Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation.Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients.Long-term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high-dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatments.Sequential, cycling maintenance therapy for post transplant multiple myeloma.Early response-based intensification of primary therapy in newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplantation: phase II study.Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival.Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients.Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
P2860
Q33376918-AB322BFE-7C76-4A7F-81EE-EF4725DCAA7AQ33709697-36D7EFFF-A575-4FFB-B27E-7EAB50A50B97Q34172071-CEF91B8F-61DF-401A-BCB8-45C8311542A1Q34275888-D63D014E-3FDB-430A-AFC1-483F071E75ACQ35071105-A6D0AA61-A801-4CF3-A58A-44B0BA69497BQ36118436-73D30865-3833-4447-B7FF-181AA3DABA78Q36163971-A8D3D984-4640-4FB1-88B3-BE33FD3D17CCQ36407446-D6652D16-8B66-43EF-9D16-9F5A93363CACQ36429735-CD98A224-E3DA-407E-A2A8-5E2A148912FBQ37577385-2E59BA38-3938-4E37-87E2-E48A119CC9ABQ37761370-869A4C00-26D3-49B2-935E-EF664A06B71BQ38122624-85CA732A-2B94-42D6-93E4-E8A75F7CE30BQ41719288-A97B5389-C90E-44FA-9E2A-D113334652F7Q43548692-AAD21FE6-C61F-4328-800E-830E8BC9D744Q43561529-93BC07E1-42FC-4C77-B958-2ED33D2FD685Q43728175-60DE0F5D-5DA4-4B75-9C8B-A0042347811BQ44857535-A469BDE2-9826-48F6-82AD-E540FAC454B4Q46509821-35C53CD3-7B12-4677-A3A4-1B651EC20767Q46772649-45619683-F013-46C2-9E9D-DE5B5D1458B7Q51741922-E7DC11E1-72DE-47D5-B7B4-DA5D7E8EB6D8Q52777488-140A43E8-EC05-4C78-9796-F0D06F6FF284Q53259579-ABA8FC66-A50F-4739-A6FD-BB7C02F5961CQ53938789-A5C6F133-44D6-4300-8277-076D0150E376
P2860
Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Autologous peripheral blood st ...... atopoyético-GETH) and PETHEMA.
@ast
Autologous peripheral blood st ...... atopoyético-GETH) and PETHEMA.
@en
type
label
Autologous peripheral blood st ...... atopoyético-GETH) and PETHEMA.
@ast
Autologous peripheral blood st ...... atopoyético-GETH) and PETHEMA.
@en
prefLabel
Autologous peripheral blood st ...... atopoyético-GETH) and PETHEMA.
@ast
Autologous peripheral blood st ...... atopoyético-GETH) and PETHEMA.
@en
P2093
P356
P1476
Autologous peripheral blood st ...... matopoyético-GETH) and PETHEMA
@en
P2093
A Escudero
C Martínez-Chamorro
D Caballero
F Hernández-Navarro
J Besalduch
P2888
P304
P356
10.1038/SJ.BMT.1701062
P407
P577
1998-01-01T00:00:00Z
P6179
1037240878